Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations.

Frontiers in immunology - 1 Jan 2021

Refaie Ayman F, Elbassiouny Batoul L, Kloc Malgorzata, Sabek Omaima M, Khater Sherry M, Ismail Amani M, Mohamed Rania H, Ghoneim Mohamed A

Abstract excerpt

Mesenchymal stem cell (MSC)-based therapy for type 1 diabetes mellitus (T1DM) has been the subject matter of many studies over the past few decades. The wide availability, negligible teratogenic risks and differentiation potential of MSCs promise a therapeutic alternative to traditional exogenous insulin injections or pancreatic transplantation. However, conflicting arguments have been reported regarding the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Glucose
Share to Cell Differentiation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 1

Share to Insulin

Share to Insulin-Secreting Cells

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 34248981
DOI: 10.3389/fimmu.2021.690623
PMCID: PMC8262452

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations.PMID 34248981Read ↗

Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 DiabetesSemantic proximity Read ↗

Adult Mesenchymal Stem Cells: A Pluripotent Population with Multiple ApplicationsSemantic proximity Read ↗

Immunomodulation by Mesenchymal Stem CellsSemantic proximity Read ↗

Novel Treatment Modalities of Type 1 Diabetes Mellitus: Opportunities and ChallengesSemantic proximity Read ↗

Therapeutic potential of mesenchymal stem cells for diabetes.Semantic proximity Read ↗

CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?Semantic proximity Read ↗

Mesenchymal stem cells—the master immunomodulatorsSemantic proximity Read ↗

Potential of mesenchymal stromal cells for improving islet transplantation outcomes.Semantic proximity Read ↗

Mesenchymal Stem/Stromal Cells: A Review for Its Use After Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Hematopoietic Stem Cells in Type 1 Diabetes.Semantic proximity Read ↗

Development of a standardised methodology for the isolation and culture of murine mesenchymal stromal cells from different tissues and comparison of their migratory, leukocyte recruitment and immunomodulatory potential in vivoSemantic proximity Read ↗

Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.